US, brand, branded generic, generic drugs. The revenue and prescription shares, and the relative prices, 2005-2015


1	Proportion of drug revenues and prescriptions in the United States for brand, branded generic, and unbranded, 2005 to 2015
2	Year	Revenue share brands	Revenue share branded generics	Revenue share unbranded generics	Prescription share brands	Prescription share branded generics	Prescription share unbranded generics	Price of branded generics relative to price of brand	Price of unbranded generic relative to price of brand
3	2005	.811	.101	.088	.399	.098	.503	.507	.086
4	2006	.800	.100	.100	.366	.092	.542	.497	.084
5	2007	.792	.108	.100	.326	.093	.581	.478	.071
6	2008	.781	.118	.101	.281	.089	.631	.477	.058
7	2009	.769	.125	.106	.254	.085	.661	.486	.053
8	2010	.757	.117	.125	.228	.075	.697	.470	.054
9	2011	.745	.119	.136	.202	.071	.727	.454	.051
10	2012	.717	.122	.161	.159	.064	.777	.423	.046
11	2013	.710	.121	.169	.136	.059	.805	.393	.040
12	2014	.721	.110	.169	.123	.056	.821	.335	.035
13	2015	.733	.107	.160	.113	.053	.834	.311	.030


1	Year	Revenue share brands	Revenue share generics	Prescription share brands	Peescription share, generics	Price of brand relative to generics
2	2015	.733	.267	.113	.887	21.550	.046
3	2016	0.74	0.26	0.11	.890	23.028	.043


1	Statistic as Excel data file
2	Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2015
3	Access data
4
5	Source	IMS Health
6	Conducted by	IMS Health
7	Survey period	2005 to 2015
8	Region	United States
9	Type of survey	n.a.
10	Number of respondents	n.a.
11	Age group	n.a.
12	Special characteristics	n.a.
13	Note	Report reflects prescription-bound products including insulins and excluding other products such as OTC. Includes all prescriptions dispensed through retail pharmacies - including independent and chain drug stores, food store pharmacies and mail order as well as long-term care facilities. Prescription counts are not adjusted for length of therapy. 90-day and 30-day prescriptions are both counted as one prescription. This statistic was assembled from several IMS Health reports.
14
15	Publication
16
17	Published by	IMS Health
18	Publication date	April 2016
19	Original source	Medicines Use and Spending in the U.S. - A Review of 2015 and Outlook to 2020, page 46
20	ID	205036


1	Statistic as Excel data file
2	Proportion of branded versus generic drug prescriptions dispensed in the United States from 2005 to 2015
3	Access data
4
5	Source	IMS Health
6	Conducted by	IMS Health
7	Survey period	2005 to 2015
8	Region	United States
9	Type of survey	n.a.
10	Number of respondents	n.a.
11	Age group	n.a.
12	Special characteristics	n.a.
13	Note	Report reflects prescription-bound products including insulins and excluding other products such as OTC. Includes all prescriptions dispensed through retail pharmacies - including independent and chain drug stores, food store pharmacies and mail order as well as long-term care facilities. Prescription counts are not adjusted for length of therapy. 90-day and 30-day prescriptions are both counted as one prescription. This statistic was assembled from several IMS Health reports.
14
15	Publication
16
17	Published by	IMS Health
18	Publication date	April 2016
19	Original source	Medicines Use and Spending in the U.S. - A Review of 2015 and Outlook to 2020, page 46
20	ID	205042